Hypertension is associated with insulin-resistance or hyperinsulinemia (1, 2). It is postulated that hyperinsulinemia may contribute to hypertension via several mechanisms (3). Although acute hyperinsulinemia activates sympathetic nerve activity (4, 5), it does not elevate blood pressure in normotensive humans (5, 6). To explain this paradox, several investigators including us reported that insulin has vasodilating effects (7, 8) , and that insulin decreases vasoreactivity to pressor agents (9, 10) . In this review article, I focus on the effects of Intra-arterially infused insulin on control of forearm vascular resistance.
Effects of Intra-Venous Insulin Infusion
Insulin stimulates Na+ -H+ exchanges and increases intracellular sodium and calcium concentrations of the vascular smooth muscle (11) . Increases in intracellular calcium concentration would increase vascular resistance and enhance vascular reactivity to pressor agents. However, previous reports regarding the effects of insulin on vascular resistance are conflicting in humans (8, 12) . Some reported increased, some no changes, and others decreased vascular resistance in the arm and leg with intravenous insulin using the euglycemic clamp method. The reported results of the effects of intravenous insulin on vasoreactivity to pressor stimuli are also conflicting. The results of intravenous insulin should be interpreted with caution, because insulin alters sympathetic tone (4, 5) by acting on the central nervous system.
Effect of Intra-Arterial Infusion of Insulin on
Resting Forearm Vascular Resistance
It has been reported that intra-arterial infusion of insulin did not alter or slightly decreased forearm vascular resistance in normotensive subjects (13) (14) (15) . We studied effects of Intra-arterial infusion of insulin at 0.15 mU/kg/min for 15-20 min on forearm blood flow in young healthy humans (mean age, 20.4 years) (9). Insulin infusion increased the local insulin level to about 120 pu/ml without changes in blood pressure and increased forearm blood flow in 4, did not change in 4, and decreased in 2 out of 10 subjects. Overall, insulin increased forearm blood flow from 4.4 to 5.6 ml/min/100 ml but this increase was not statistically significant. In another set of experiment in young healthy subjects, the overall increase in forearm blood flow was by 20%. With the intra-arterial infusion method, systemic effects of insulin were excluded because the systemic level of insulin was 11 pu/ml. Thus, it is likely that acute hyperinsulinemia may increase forearm blood flow in some but not in all and the vasodilating effects of insulin may be rather small.
Effects of Insulin on Vasoreactivity
Previous studies with intra-venous insulin by the use of the euglycemic clamp method demonstrated that insulin decreased or did not alter vascular reactivity to vasoconstricting stimuli (16, 17) . However, Gans et al. recently reported that intravenous insulin augmented blood pressure response to norepinephrine but not to angiotensin II (18) . Thus, reported results are conflicting. We examined whether local hyperinsulinemia during intra-arterial infusion of insulin altered vascular reactivity to phenylephrine and angiotensin II in young healthy subjects (9). Representative recordings are shown in Fig. 1 . Before insulin infusion, angiotensin II caused dose-dependent decreases in forearm blood flow without changes in blood pressure. Thus, angiotensin II caused vasoconstriction dose-dependently. In this particular subject insulin infusion greatly increased resting forearm blood flow from 3.8 to 7.3 ml/min/100 ml and attenuated angiotensin II-induced vasoconstriction. Pooled data are shown in Fig. 2 . Insulin infusion slightly decreased resting forearm vascular resistance (not statistically significant) and attenuated vasoconstriction in response to phenylephrine and angiotensin II in young healthy subjects. We also examined vasoconstrictor responses to phenylephrine and angiotensin II in young hypertensive subjects (19) . Representative recordings are shown in Fig. 3 . Insulin infusion slightly increased resting forearm blood flow. In contrast to normotensive subjects, angiotensin II-induced forearm vasoconstriction was similar before and during insulin infusion. Pooled data are shown Fig. 4 . Insulin did not alter vasoconstriction in response to phenylephrine and angiotensin II. Thus, in hypertensive subjects, anti-vasoconstricting effects of insulin were lost. We suggest that the balance between the pressor and depressor effects of insulin may be altered in favor of a pressor effect in patients with hypertension.
Vasodilating Mechanisms of Insulin
As mentioned above, insulin may cause peripheral vasodilation in some normotensive subjects. We determined the role of the endothelium in insulin-induced vasodilation in young healthy volunteers. Intra-arterial infusion of insulin increased forearm blood flow from 4.9± 1.7 at rest to 5.9± 1.8 ml/min/ 100 ml and increased 6-keto prostaglandin Fia (a metabolite of prostacyclin) in the venous effluents from 14.9 ± 3.3 to 29.3 ± 5.7 pg/ml. Indomethacin (75 mg, P.O) abolished insulin-induced vasodilation and increases in prostaglandin Fia. Intra-arterial infusion of L-NMMA (a blocker of oxide synthesis) caused marked vasoconstriction but did not affect insulin-induced vasodilation. Our results may suggest that insulin-induced vasodilation is mediated by prostacyclin but not by nitric oxide in the forearm of healthy humans. Although we did not examine the role of endothelium in control of peripheral circulation by insulin in hypertensive subjects, it is Fig. 1 . Representative plethysmographic recordings show changes in forearm blood flow (FBF) during intra-arteral infu sion o f angiotensin II (Ang 11) at graded doses before and during simultaneous intra-arterial infusion insulin. Angiotensin caused progressive decreases in forearm blood flow. Note that the baseline blood flow was significantly greater during insulin infusion and that decreases in forearm blood flow in response to phenylephrine were smaller during insulin infusion than before insulin infusion.
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Conclusion
In summary, local hyperinsulinemia at physiological levels during intra-arterial infusion of insulin causes vasodilation in some healthy young subjects but not in all, and attenuates vascular reactivity to pressor stimuli in healthy young subjects. These may be mechanisms by which intravenous infusion of insulin dose not elevate blood pressure in normotensive subjects despite its sympathetic activation. In contrast, the anti-vasoconstricting effects of insulin are lost in hypertensive subjects which may contribute to the development and maintenance of hypertension. o f graded doses o f 11 increases forearm infusion. cont, con-
